Skip to main content

Advertisement

Log in

Macrophage migration inhibitory factor: a regulator of MMP13 and inflammation in titanium particles-stimulated air pouch in vivo

  • Published:
Molecular and Cellular Biochemistry Aims and scope Submit manuscript

Abstract

Macrophage migration inhibitory factor (MIF) is a significant regulator of inflammatory diseases, and local inflammation plays an important role in the aseptic loosening of failed total hip arthroplasty (THA). A high-level MIF expression was found in the interfacial membrane around implants. However, the cause of increased MIF expression and the action of MIF in the process of aseptic-loosening implant is still unknown. This study is to investigate MIF expression and its upregulating effect on matrix metalloproteinases (MMPs) expression in the particles-stimulated air pouches in mice that appear to closely resemble the interfacial membranes. A total of 48 murine air pouches were divided into four groups, and were injected with PBS, titanium particles suspensions, titanium particles suspensions with neutralizing antibody of MIF, and titanium particles suspensions with normal IgG, respectively. Histological and cytokine responses were evaluated. The inflammatory reaction of air pouch membranes induced by titanium particles was significantly suppressed by neutralizing antibody. The levels of MIF protein and mRNA were significantly increased in the titanium particles-stimulated air pouch membranes compared with the control groups. So were the levels of MMP13 protein and mRNA. However, the levels of MMP13 protein and mRNA were significantly reduced by neutralizing antibody. Our study demonstrates that titanium particles can cause the air pouch membranes to increase the expression of MIF, which upregulates the production of MMP13 and induces inflammatory reaction in vivo. The results indicate that MIF may play an important role in the process of aseptic-loosening implants after THA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. David JR (1966) Delayed hypersensitivity in vitro: its mediation by cell free substances forms by lymphoid cell-antigen interaction. Proc Natl Acad Sci USA 56(1):72–77

    Article  PubMed  CAS  Google Scholar 

  2. Bloom BR, Bennett B (1966) Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153(731):80–82

    Article  PubMed  CAS  Google Scholar 

  3. Calandra T, Bernhagen J, Mitchell RA, Bucala R (1994) The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. J Exp Med 179(6):1895–1902

    Article  PubMed  CAS  Google Scholar 

  4. Calandra T, Roger T (2003) Macrophage migration inhibitory factor: a regulator of innate immunity. Nat Rev Immunol 3(10):791–800

    Article  PubMed  CAS  Google Scholar 

  5. Calandra T, Bernhagen J, Mets CN, Spiegel LA, Bacher M, Donnelly T, Cerami A, Bucala R (1995) MIF as a glucocorticoid induced modulator of cytokine production. Nature 377(6544):68–71

    Article  PubMed  CAS  Google Scholar 

  6. Harris WH (1995) The problem is osteolysis. Clin Orthop Relat Res 311:46–53

    PubMed  Google Scholar 

  7. Clohisy JC, Calvert G, Tull F, McDonald D, Maloney WJ (2004) Reasons for revision hip surgery: a retrospective review. Clin Orthop Relat Res 429:188–192

    Article  PubMed  Google Scholar 

  8. Harris WH, Schiller AL, Scholler JM, Freiberg RA, Scott R (1976) Extensive localized bone resorption in the femur following total hip replacement. J Bone Joint Surg Am 58(5):612–618

    PubMed  CAS  Google Scholar 

  9. Onodera S, Nishihira J, Iwabuchi K, Koyama Y, Yoshida K, Tanaka S, Minami A (2002) Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. J Biol Chem 277(10):7865–7874

    Article  PubMed  CAS  Google Scholar 

  10. Wagner S, Gollwitzer H, Wernicke D, Langer R, Siebenrock KA, Hofstetter W (2008) Interface membrane fibroblasts around aseptically loosened endoprostheses express MMP-13. J Orthop Res 26(2):143–152

    Article  PubMed  Google Scholar 

  11. Suzuki K, Onodera S, Matsuno T, Kaneda K, Nishihira J (1996) Identification of macrophage migration inhibitory factor in synovial membranes of loosened total joint replacement. Biochem Mol Biol Int 39(3):529–537

    PubMed  CAS  Google Scholar 

  12. Sedgwick AD, Sin YM, Edwards JC, Willoughby DA (1983) Increased inflammatory reactivity in newly formed lining tissue. J Pathol 141(4):483–495

    Article  PubMed  CAS  Google Scholar 

  13. Edwall L, Carlström K, Jonasson AF (2005) Markers of collagen synthesis and degradation in urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodyn 24(4):319–324

    Article  PubMed  CAS  Google Scholar 

  14. Wooley PH, Morren R, Andary J, Sud S, Yang SY, Mayton L, Markel D, Sieving A, Nasser S (2002) Inflammatory responses to orthopaedic biomaterials in the murine air pouch. Biomaterials 23:517–526

    Article  PubMed  CAS  Google Scholar 

  15. Phillips PA, McCarroll JA, Park S, Wu MJ, Pirola R, Korsten M, Wilson JS, Apte MV (2003) Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover. Gut 52(2):275–282

    Article  PubMed  CAS  Google Scholar 

  16. Bernhagen J, Calandra T, Mitchell RA, Martin SB, Tracey KJ, Voelter W, Manogue KR, Cerami A, Bucala R (1993) MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia. Nature 365(6448):756–759

    Article  PubMed  CAS  Google Scholar 

  17. Bernhagen J, Mitchell RA, Calandra T, Voelter W, Cerami A, Bucala R (1994) Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33(47):14144–14155

    Article  PubMed  CAS  Google Scholar 

  18. Mizue Y, Nishihira J, Miyazaki T, Fujiwara S, Chida M, Nakamura K, Kikuchi K, Mukai M (2000) Quantitation of macrophage migration inhibitory factor (MIF) using the one-step sandwich enzyme immunosorbent assay: elevated serum MIF concentrations in patients with autoimmune diseases and identification of MIF in erythrocytes. Int J Mol Med 5(4):397–403

    PubMed  CAS  Google Scholar 

  19. Chesney J, Metz C, Bacher M, Peng T, Meinhardt A, Bucala R (1999) An essential role for macrophage migration inhibitory factor (MIF) in angiogenesis and the growth of a murine lymphoma. Mol Med 5(3):181–191

    PubMed  CAS  Google Scholar 

  20. Nishihira J, Koyama Y, Mizue Y (1998) Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 10(3):199–205

    Article  PubMed  CAS  Google Scholar 

  21. Ogawa H, Nishihira J, Sato Y, Kondo M, Takahashi N, Oshima T, Todo S (2000) An antibody for macrophage migration inhibitory factor suppresses tumour growth and inhibits tumour-associated angiogenesis. Cytokine 12(4):309–314

    Article  PubMed  CAS  Google Scholar 

  22. Leech M, Metz C, Hall P, Hutchinson P, Gianis K, Smith M, Weedon H, Holdsworth SR, Bucala R, Morand EF (1999) Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum 42(8):1601–1608

    Article  PubMed  CAS  Google Scholar 

  23. Morand EF, Leech M (2005) Macrophage migration inhibitory factor in rheumatoid arthritis. Front Biosci 10:12–22

    Article  PubMed  CAS  Google Scholar 

  24. Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, Morand E (2003) Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 48(1):103–109

    Article  PubMed  CAS  Google Scholar 

  25. Schurigt U, Pfirschke C, Irmler IM, Hückel M, Gajda M, Janik T, Baumgrass R, Bernhagen J, Bräuer R (2008) Interactions of T helper cells with fibroblast-like synoviocytes: up-regulation of matrix metalloproteinases by macrophage migration inhibitory factor from both Th1 and Th2 cells. Arthritis Rheum 58(10):3030–3040

    Article  PubMed  CAS  Google Scholar 

  26. Ichiyama H, Onodera S, Nishihira J, Ishibashi T, Nakayama T, Minami A, Yasuda K, Tohyama H (2004) Inhibition of joint inflammation and destruction induced by anti-type II collagen antibody/lipopolysaccharide(LPS)-induced arthritis in mice due to deletion of macrophage migration inhibitory factor (MIF). Cytokine 26(5):187–194

    Article  PubMed  CAS  Google Scholar 

  27. Best AJ, Fender D, Harper WM, McCaskie AW, Oliver K, Gregg PJ (1998) Current practice in primary total hip replacement: results from the National Hip Replacement Outcome Project. Ann R Coll Surg Engl 80(5):350–355

    PubMed  CAS  Google Scholar 

  28. Goodman SB, Lind M, Song Y, Smith RL (1998) In vitro, in vivo, and tissue retrieval studies on particulate debris. Clin Orthop Relat Res 352:25–34

    Article  PubMed  Google Scholar 

  29. Archibeck MJ, Jacobs JJ, Roebuck KA, Glant TT (2001) The basic science of periprosthetic osteolysis. Instr Course Lect 50:185–195

    PubMed  CAS  Google Scholar 

  30. Atkins RM, Langkamer VG, Perry MJ, Elson CJ, Collins CM (1997) Bone–membrane interface in aseptic loosening of total joint arthroplasties. J Arthroplasty 12(4):461–464

    Article  PubMed  CAS  Google Scholar 

  31. Goodman SB, Huie P, Song Y, Schurman D, Maloney W, Woolson S, Sibley R (1998) Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements. J Bone Joint Surg Br 80(3):531–539

    Article  PubMed  CAS  Google Scholar 

  32. Goldring SR, Schiller AL, Roelke M, Rourke CM, O’Neill DA, Harris WH (1983) The synovial-like membrane at the bone–cement interface in loose total hip replacements and its proposed role in bone lysis. J Bone Joint Surg Am 65(5):575–584

    PubMed  CAS  Google Scholar 

  33. Kim KJ, Rubash HE, Wilson SC, D’Antonio JA, McClain EJ (1993) A histological and biochemical comparison of the interface tissues in cementless and cemented hip prostheses. Clin Orthop Relat Res 287:142–152

    PubMed  Google Scholar 

  34. Yokohama Y, Matsumoto T, Hirakawa M, Kuroki Y, Fujimoto N, Imai K, Okada Y (1995) Production of matrix metalloproteinases at the bone–implant interface in loose total hip replacements. Lab Invest 73(6):899–911

    PubMed  CAS  Google Scholar 

  35. Syggelos SA, Eleftheriou SC, Giannopoulou E, Panagiotopoulos E, Aletras AJ (2001) Gelatinolytic and collagenolytic activity in periprosthetic tissues from loose hip endoprostheses. J Rheumatol 28(6):1319–1329

    PubMed  CAS  Google Scholar 

  36. Ma GF, Ali A, Verzijl N, Hanemaaijer R, TeKoppele J, Konttinen YT, Salo J (2006) Increased collagen degradation around loosened total hip replacement implants. Arthritis Rheum 54(9):2928–2933

    Article  PubMed  Google Scholar 

  37. Gelb H, Schumacher HR, Cuckler J, Baker DG (1994) In vivo inflammatory response to polymethylmethacrylate particulate debris: effect of size, morphology, and surface area. J Orthop Res 12(1):83–92

    Article  PubMed  CAS  Google Scholar 

  38. Chambers TJ, Fuller K (1985) Bone cells predispose bone surfaces to resorption by exposure of mineral to osteoclastic contact. J Cell Sci 76:155–165

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Xianlong Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pan, X., Mao, X., Cheng, T. et al. Macrophage migration inhibitory factor: a regulator of MMP13 and inflammation in titanium particles-stimulated air pouch in vivo. Mol Cell Biochem 357, 313–321 (2011). https://doi.org/10.1007/s11010-011-0902-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11010-011-0902-6

Keywords

Navigation